Physician profile
Milimir D Arsov
NPI 1841277159
$1,962.72
in general payments reported to CMS, 2019-2025
7 companies · $78.96 in 2025
The $78.96 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $252 · 2021: $459 · 2022: $398 · 2023: $20.60 · 2024: $38.92 · 2025: $78.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $799.89 | 2021-2025 | Corevalve Evolut R, Resolute Onyx, Symplicity G3 |
| Abiomed | $513.26 | 2019-2025 | |
| Abbott Laboratories | $254.04 | 2019-2021 | |
| Medtronic Vascular, INC. | $137.85 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $132.25 | 2019 | |
| Boston Scientific Corporation | $86.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $38.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milimir Arsov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.